The size of the Empty Capsules Market in the Asia Pacific region was worth USD 297.95 million in 2020 and estimated to be growing at a CAGR of 12.1%, to reach $527.45 million by 2025.
Empty Capsules are generally made from Gelatin, which is derived either from plant or animal origin. These capsules are used as a dosage form for prescription and OTC drugs, nutrient supplements, and herbal products.
Asia-Pacific, empty capsules market is driven by growing applications in pharmaceutical and nutraceuticals companies. Growing consumer preference towards capsule-based formulations and increasing disposable income are key factors driving the market growth.
However, rapidly increasing raw material costs and issues associated with the consumption of capsules containing animal-derived ingredients are the key factors restraining the growth of the Asia Pacific Empty Capsules market.
This research report on the APAC Empty Capsules Market has been segmented and sub-segmented into the following categories:
By Product:
By Therapeutic Application:
By End User:
By Country:
Gelatin Capsules are the largest product segment, while Non-Gelatin capsules are estimated to be the fastest segment with a CAGR of XX% due to increasing preference for vegetable origin capsules. The pharmaceutical industry is the largest end-user segment for the Empty capsules market.
Asia-Pacific is estimated to be the fastest-growing region due to increasing government support and increasing demand for nutraceuticals and cosmeceuticals. Within Asia-Pacific, India is the fastest-growing region due to its high population base and increasing healthcare expenditure.
Leading companies in the APAC Empty Capsules Market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd, and Sunil Healthcare Limited.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
